| Sno | Abstract Title | Abstract Type | Edit | Delete |
|---|---|---|---|---|
| 1 | TRANSLATION OF PVSG/WHO INTO THE CLINICAL, LABORATORY, MOLECULAR AND PATHOLOGICAL (2018 CLMP) DEFINED MYELOPROLIFERATIVE NEOPLASMS CAUSED BY JAK2V617F JAK2EXON12, CALR, MPL AND TPO DRIVER MUTATIONS ARE DISTINCT BLOOD AND COAGULATION DISORDERS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS TOWARDS 2020 AND BEYOND Jan Jacques Michiels HTML | PDF | Add Speaker+ [1 ] |
Keynote | ||
| 2 | SCIENTIFIC RATIONALE FOR LOWER DOSE OF IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA Varsha Gandhi HTML | PDF | Add Speaker+ [1 ] |
Keynote |